ArticleTranslational lung cancer research2026

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.

Yasuhito Nunomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.